🇨🇦 PF-06741086 in Canada

PF-06741086 (pf-06741086) regulatory status in Canada.

Marketing authorisation

PF-06741086 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PF-06741086 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for PF-06741086 in Canada?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.